Loading...
Loading...
Indian Pharmaceutical Exporter Β· #3 for Ephedrine Β· $1.8M export value Β· DGFT Verified
Laborate Pharmaceuticals India Ltd is the #3 Indian exporter of Ephedrine with $1.8M in export value and 35 verified shipments. Laborate Pharmaceuticals India Ltd holds a 9.0% market share in Ephedrine exports across 1 countries.

| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $5.3M | 107 | 50.0% |
| NIGERIA | $2.3M | 46 | 21.5% |
| CANADA | $1.6M | 31 | 14.5% |
| KENYA | $260.7K | 14 | 2.4% |
| ALGERIA | $231.2K | 5 | 2.2% |
| UNITED KINGDOM | $194.5K | 6 | 1.8% |
| MALAYSIA | $143.2K | 11 | 1.3% |
| SENEGAL | $114.2K | 9 | 1.1% |
| PERU | $97.3K | 3 | 0.9% |
| SUDAN | $92.5K | 11 | 0.9% |
India exports Ephedrine to 56 countries. The top destination is UNITED STATES (50.0%), followed by NIGERIA and CANADA.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| VITA HEALTH PRODUCTS INC | CANADA | $1.4M | 29 |
| OHM LABORATORIES INC | UNITED STATES | $1.4M | 28 |
| EMBASSY PHARMACEUTICAL AND | NIGERIA | $1.2M | 24 |
| RXCROSS ROADS 3PL LLC | UNITED STATES | $850.0K | 17 |
| RXCROSSROADS 3PL LLC | UNITED STATES | $700.0K |
India exported $9.8M worth of Ephedrine through 389 shipments from 59 suppliers to 56 countries, serving 116 buyers globally. Laborate Pharmaceuticals India Ltd contributes $1.8M to this total, accounting for 9.0% of India's Ephedrine exports.
Laborate Pharmaceuticals India Ltd's average Ephedrine shipment value is $50.0K per consignment, based on 35 shipments totaling $1.8M.
Laborate Pharmaceuticals India Ltd ranks #3 among 59 Indian Ephedrine exporters with a 9.0% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($2.3M), LABORATE PHARMACEUTICALS INDIA LTD ($1.8M), GRANULES INDIA LIMITED ($1.4M). Laborate Pharmaceuticals India Ltd processed 35 shipments to 1 destination countries.
What Laborate Pharmaceuticals India Ltd must comply with to export Ephedrine to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10β18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $2.3M | 45 | 4 | $50.0K |
| 3 | LABORATE PHARMACEUTICALS INDIA LTD β | $1.8M | 35 | 1 | $50.0K |
| 4 | GRANULES INDIA LIMITED | $1.4M | 29 | 1 | $50.0K |
| 1 | MANKIND PHARMA LIMITED | $1.4M | 27 | 1 | $50.0K |
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR | 57 | 14.7% |
| DELHI AIR CARGO ACC (INDEL4) | 37 | 9.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 28 | 7.2% |
| PATLI ICD | 28 | 7.2% |
| SAHAR AIR | 26 | 6.7% |
| BANGALORE AIR | 20 | 5.1% |
| HYDERABAD ACC (INHYD4) | 14 | 3.6% |
| BANGALORE ACC (INBLR4) | 13 | 3.3% |
Latest developments and market context
Detailed market intelligence for Ephedrine β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Laborate Pharmaceuticals India Ltd's Ephedrine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
| 14 |
| OHM LABORATORIES INC. | UNITED STATES | $450.0K | 9 |
| EMBASSY PHARMACEUTICAL & CHEMICALS | NIGERIA | $400.0K | 8 |
| EMBASSY PHARMACEUTICAL AND CHEMICALS LIMITED | NIGERIA | $350.0K | 7 |
| DR REDDYS LABORATORIES INC | UNITED STATES | $250.0K | 5 |
| RXCROSSROADS THREEPPL LLC | UNITED STATES | $150.0K | 3 |
India's Ephedrine is purchased by 116 buyers worldwide. The top buyer is VITA HEALTH PRODUCTS INC (CANADA), followed by OHM LABORATORIES INC and EMBASSY PHARMACEUTICAL AND.
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6β18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Laborate Pharmaceuticals India Ltd ranks #3 among 59 Indian Ephedrine exporters. Average shipment value of $50.0K compared to the market average of $166.9K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and GRANULES INDIA LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 56+ countries, 116+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Laborate Pharmaceuticals India Ltd.
Request DemoView Pricing βTrade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ephedrine. For current shipment-level data, contact TransData Nexus.